Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)

Groot, S. de; Janssen, L.G.M.; Charehbili, A.; Dijkgraaf, E.M.; Smit, V.T.H.B.M.; Kessels, L.W.; ... ; Kroep, J.R. (2015)

Article / Letter to editor

• Breast cancer
• Thyroid hormones
• Chemotherapy
• Toxicity
• pCR

• All authors: Groot, S. de; Janssen, L.G.M.; Charehbili, A.; Dijkgraaf, E.M.; Smit, V.T.H.B.M.; Kessels, L.W.; Bochove, A. van; Laarhoven, H.W.M. van; Kranenbarg, E.M.K.; Leeuwen-Stok, A.E. van; Velde, C.J.H. van de; Putter, H.; Nortier, J.W.R.; Hoeven, J.J.M. van der; Pijl, H.; Kroep, J.R.
• Date: 2015-01-31
• Journal: Breast Cancer Research and Treatment
• Volume: 149
• Issue: 2
• Pages: 461 - 466
• DOI: doi:10.1007/s10549-014-3256-4